291
Louis Kyron, CPA, CGA
Editor in Chief
@LouisKyron
CCIM:
TGOD: Absolutely, evidence supports cannabis assisting people with countless ailments including sleep disorder, anxiety and chronic pain. The aging population represents an important consumer base that we want to be able to provide premium organic cannabis products to. TGOD aims to provide patients and customers with novel and effective dose-controlled delivery systems that are safer, more standardized, and more discreet than most current cannabinoid delivery systems.
CCIM:
TGOD: Absolutely not. Remember, our entire domestic operations are fully funded, we have over $300 million dollars in cash now with a significant portion earmarked to these initiatives. We will continue to look for opportunities that make sense for us, both internationally, and domestically. With the experience our senior executives have in the beverage and beverage alcohol industries (125+ years) coupled with our newly formed beverage division, 40,000 kg productive capacity beverage specific facility, and new hires like Prem Virmani (see press release here) I believe we are in an excellent position to form a multitude of strategic partnerships across the board.
CCIM: